PDSB
PDS Biotechnology Corp
NASDAQ · Healthcare · Biotechnology · US
$0.81
−4.36%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-17.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Mar 3, 2026 | CONN GREGORY · officer: Chief Scientific Officer | A-Award | 150,000 | $0.98 |
| Mar 3, 2026 | BEDU-ADDO FRANK · director, officer: President/CEO | A-Award | 548,782 | $0.98 |
| Mar 3, 2026 | Brown Spencer D. · officer: Senior VP, General Counsel | A-Award | 300,000 | $0.98 |
| Mar 3, 2026 | Toutain Stephan · officer: Chief Operating Officer | A-Award | 300,000 | $0.98 |
| Mar 3, 2026 | Freitag Gregory Gene · director | A-Award | 54,876 | $0.98 |
| Mar 3, 2026 | Iliev Ilian · director | A-Award | 54,876 | $0.98 |
| Mar 3, 2026 | Ali-Jackson Kamil · director | A-Award | 54,876 | $0.98 |
| Mar 3, 2026 | BRAWLEY OTIS W · director | A-Award | 54,876 | $0.98 |
| Mar 3, 2026 | Glover Stephen C. · director | A-Award | 54,876 | $0.98 |
| Mar 3, 2026 | Boesgaard Lars · officer: Chief Financial Officer | A-Award | 300,000 | $0.98 |
| Mar 3, 2026 | Shepard Kirk V. · officer: Chief Medical Officer | A-Award | 300,000 | $0.98 |
| Jul 25, 2025 | Brown Spencer D. · officer: Senior VP, General Counsel | A-Award | 150,000 | $1.79 |
| Jul 25, 2025 | Toutain Stephan · officer: Chief Operations Officer | A-Award | 150,000 | $1.79 |
| Jul 25, 2025 | CONN GREGORY · officer: Chief Scientific Officer | A-Award | 40,000 | $1.79 |
| Jul 25, 2025 | CONN GREGORY · officer: Chief Scientific Officer | A-Award | 46,648 | $5.87 |
| Jul 25, 2025 | Boesgaard Lars · officer: Chief Financial Officer | A-Award | 150,000 | $1.79 |
| Jul 25, 2025 | Brown Spencer D. · officer: Senior VP, General Counsel | A-Award | 56,000 | $5.87 |
| Jul 25, 2025 | Shepard Kirk V. · officer: Chief Medical Officer | A-Award | 150,000 | $1.79 |
| Jul 25, 2025 | BEDU-ADDO FRANK · director, officer: President/CEO | A-Award | 150,000 | $1.79 |
| Jul 25, 2025 | BEDU-ADDO FRANK · director, officer: President/CEO | A-Award | 300,000 | $5.87 |
| Jun 11, 2025 | Iliev Ilian · director | A-Award | 22,700 | $1.75 |
| Jun 11, 2025 | BRAWLEY OTIS W · director | A-Award | 22,700 | $1.75 |
| Jun 11, 2025 | Freitag Gregory Gene · director | A-Award | 22,700 | $1.75 |
| Jun 11, 2025 | Glover Stephen C. · director | A-Award | 22,700 | $1.75 |
| Jun 11, 2025 | Ali-Jackson Kamil · director | A-Award | 22,700 | $1.75 |
| Mar 3, 2025 | Freitag Gregory Gene · director | Purchase | 15,060 | $1.66 |
| Mar 3, 2025 | Glover Stephen C. · director | Purchase | 15,061 | $1.66 |
| Jun 25, 2024 | Freitag Gregory Gene · director | A-Award | 9,000 | $2.86 |
| Jun 25, 2024 | Glover Stephen C. · director | A-Award | 9,000 | $2.86 |
| Jun 25, 2024 | BRAWLEY OTIS W · director | A-Award | 9,000 | $2.86 |
Institutional positioning
13F filings over the trailing two quarters
New 23Increased 24Reduced 17Sold out 4
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,699,315 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,631,089 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 660,228 | May 15, 2026 |
| Focus Partners Wealth | New Position | 642,177 | Aug 12, 2026 |
| Quantinno Capital Management LP | New Position | 642,177 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 607,639 | Aug 7, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 587,139 | Aug 12, 2026 |
| BLACKROCK, INC. | Increased | 554,048 | May 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Increased | 357,144 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 348,301 | Sep 2, 2026 |
| Militia Capital Management LLC | New Position | 331,800 | Aug 12, 2026 |
| Caption Management, LLC | Unchanged | 319,100 | Aug 14, 2026 |
| CAPTION MANAGEMENT, LLC | New Position | 319,100 | May 15, 2026 |
| MORGAN STANLEY | Increased | 313,922 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 307,311 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 3, 2026